Resources

New evidence questions the idea of what is normal.

A new finding from the SCALE trial.

Gastric bypass surgery may treat type 2 diabetes in selected patients.

Changes in serum metabolomic profile affect eGFR in patients with type 1 diabetes.

Genetic predisposition to a higher waist-to-hip ratio may lead to diabetes.

Proponents may suggest an advantage of one over the other, but the data is not so clear.

The diabetes drug empagliflozin reduces all of the following CV risk factors except: a. Blood pressure b. Visceral adiposity c. Low-density lipoprotein cholesterol d. Triglycerides e. Atrial stiffness Follow the link to see if you got it right!

Should physicians be able to help patients end their lives? Follow the link to share your opinion and see what your colleagues say.

Woman, 57 years of age, prediabetes, hyperlipidemia, class I obesity and history of gestational diabetes. I’ve been working with her for the past two years. The first year she was very motivated because of her new diagnosis of prediabetes and her weight being what it was. Her son was getting married and she wanted to lose weight for the wedding. We discussed a plan for her.

Blandine Lacroix talks with Diabetes in Control Publisher Steve Freed at the 2016 AACE Meeting. In part 5, the conclusion of this Exclusive Interview, Blandine Lacroix charges the medical community with understanding obesity and being of support to those with the disease.